Seno Medical’s Imagio® Breast Imaging System Named Finalist for Medical Device Excellence Awards
[SAN ANTONIO, TX – March 29, 2022] Seno Medical’s Imagio® Breast Imaging System has been named a finalist in the 2022 Medical Device Excellence Awards, in the Radiological, Imaging, and Electromechanical Devices category.
Seno Medical’s Imagio® Breast Imaging System Named Science and Medical Category Finalist in 2022 Edison Awards Program
Seno Medical’s Imagio® Breast Imaging System has been named a finalist in the 2022 Edison Awards competition in the Science and Medical category and Diagnostics sub-category.
[SAN ANTONIO, TX – February 8, 2022] The Edison Awards program is an annual competition honoring excellence in new product and service development, marketing, human-centered design, and innovation.
Poster Presentation at RSNA Compares Seno Medical’s OA/US Breast Imaging with AI Decision Support to Ultrasound Alone; Finds Significantly Better Specificity to Support Clinical Decision Making Conf
A study presented at the Radiological Society of North America (RSNA)’s annual meeting showed Texas-based Seno Medical Instruments, Inc. (Seno)’s Imagio® opto-acoustic ultrasound (OA/US) breast imaging provides significantly better specificity than ultrasound alone.
[SAN ANTONIO, TX – December 1, 2021]
Seno Medical Launches CONFIDENCE Registry Study for Imagio® Breast Imaging System
Prospective, controlled multi-center observational registry will include ~12 sites and 600 patients to collect data on opto-acoustic/ultrasound (OA/US) system.
[SAN ANTONIO, TX – October 21, 2021] Texas-based Seno Medical Instruments, Inc. (Seno) has launched its CONFIDENCE registry to evaluate the efficacy
FDA Approves Seno Medical’s Ground-Breaking Breast Cancer Diagnostic Technology
Seno’s Imagio® Breast Imaging System helps physicians differentiate between benign and malignant breast lesions using a novel combination of ultrasound and opto-acoustic technology.
[SAN ANTONIO, TX – January 19, 2021] The Center for Devices and Radiological Health (CDRH) of the US
Seno Medical and “Know Your Lemons” Highlight Importance of Education and Self-Exam for Early Breast Cancer Detection
New survey demonstrates women play a critical role in symptom(s) discovery
SAN ANTONIO, Nov. 14, 2019 /PRNewswire/ — A recent survey of women in the Netherlands found that 79 percent of respondents diagnosed with breast cancer noticed symptoms prior to being